Trademark: 87232859
Word
LYNXZIMO
Status
Dead
Status Code
710
Status Date
Friday, February 23, 2024
Serial Number
87232859
Registration Number
5259630
Registration Date
Tuesday, August 8, 2017
Mark Type
4000
Filing Date
Thursday, November 10, 2016
Published for Opposition
Tuesday, April 4, 2017
Cancellation Date
Friday, February 23, 2024

Trademark Owner History
Novartis AG - Original Registrant

Classifications
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Trademark Events
Feb 23, 2024
Cancelled Sec. 8 (6-Yr)
Aug 8, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Aug 8, 2017
Registered-Principal Register
Jun 30, 2017
1(B) Basis Deleted; Proceed To Registration
Jun 13, 2017
Notice Of Allowance Cancelled
Jun 30, 2017
Case Assigned To Intent To Use Paralegal
Jun 13, 2017
Teas Delete 1(B) Basis Received
May 30, 2017
Noa E-Mailed - Sou Required From Applicant
Apr 4, 2017
Official Gazette Publication Confirmation E-Mailed
Apr 4, 2017
Published For Opposition
Mar 15, 2017
Notification Of Notice Of Publication E-Mailed
Feb 28, 2017
Law Office Publication Review Completed
Feb 21, 2017
Approved For Pub - Principal Register
Feb 8, 2017
Teas/Email Correspondence Entered
Feb 8, 2017
Correspondence Received In Law Office
Jan 31, 2017
Assigned To Lie
Jan 12, 2017
Teas Response To Suspension Inquiry Received
Dec 29, 2016
Notification Of Letter Of Suspension E-Mailed
Dec 29, 2016
Letter Of Suspension E-Mailed
Dec 29, 2016
Suspension Letter Written
Dec 27, 2016
Assigned To Examiner
Nov 16, 2016
New Application Office Supplied Data Entered
Nov 14, 2016
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24